EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Efficacy and Safety of Deracoxib for the Control of Postoperative Pain and Inflammation Associated with Dental Surgery in Dogs

Stephen E Bienhoff, Eric S Smith, Linda M Roycroft, Elizabeth S Roberts, Larry D Baker

ISRN Veterinary Science · 2011

DOI: 10.5402/2011/593015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ISRN Veterinary Science, 2011. Verfasst von Stephen E Bienhoff und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of New Product Development, Novartis Animal Health US, Inc., Greensboro, NC 27408, USA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Novartis.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The efficacy and safety of deracoxib administered at 1-2 mg/kg/day for 3 days was assessed for the control of postoperative pain and inflammation associated with dental surgery in dogs. Client-owned dogs scheduled for dental extractions were premedicated with butorphanol and randomly assigned to receive either deracoxib ( n = 31 ) or placebo ( n = 31 ) preoperatively and again once daily for 2 additional days. Dogs were evaluated prior to and after surgery using a modified Glasgow Composite Pain Scale (mGCPS). Dogs could be rescued at any time if they scored ≥4 on the mGCPS or in cases of obvious discomfort. Rescued dogs were considered treatment failures for determining treatment response and were removed from the study. Of the 62 dogs enrolled, 57 were usable for the efficacy analyses and all were assessed for safety. Four of 27 deracoxib-treated dogs (14.8%) were rescued compared to 20 of 30 placebo dogs (66.7%) ( P = 0.0006 ). Deracoxib-treated dogs also had numerically lower mGCPS scores. Eight of 31 deracoxib dogs (26%) had adverse events reported compared to 6 of 31 placebo dogs (19%). Results indicate perioperative administration of deracoxib to dogs at 1-2 mg/kg/day for 3 days significantly improves analgesia after dental surgery.

Autor:innen und Institutionen

  • Department of New Product Development, Novartis Animal Health US, Inc., Greensboro, NC 27408, USA.

Förderung

  • Novartis

Zitieren

APA

Bienhoff, S. E., Smith, E. S., Roycroft, L. M., Roberts, E. S., & Baker, L. D. (2011). Efficacy and Safety of Deracoxib for the Control of Postoperative Pain and Inflammation Associated with Dental Surgery in Dogs. ISRN Veterinary Science. https://doi.org/10.5402/2011/593015

Vancouver

Bienhoff SE, Smith ES, Roycroft LM, Roberts ES, Baker LD. Efficacy and Safety of Deracoxib for the Control of Postoperative Pain and Inflammation Associated with Dental Surgery in Dogs. ISRN Veterinary Science. 2011. doi:10.5402/2011/593015

BibTeX
@article{Bienhoff2011,
  author = {Bienhoff, Stephen E and Smith, Eric S and Roycroft, Linda M and Roberts, Elizabeth S and Baker, Larry D},
  title = {Efficacy and Safety of Deracoxib for the Control of Postoperative Pain and Inflammation Associated with Dental Surgery in Dogs},
  journal = {ISRN Veterinary Science},
  year = {2011},
  doi = {10.5402/2011/593015}
}
Kostenlos starten →